HPV Vaccines
Star Calls Attention to Oral Sex Throat Cancer Link, Raising Awareness of HPV Vaccine
- Details
- Category: Human Papillomavirus (HPV)
- Published on Thursday, 06 June 2013 00:00
- Written by Liz Highleyman
Actor Michael Douglas' claim that his throat cancer was caused by oral sex has brought new attention to the link between human papillomavirus (HPV) and oral cancer, as well as heightened interest in HPV vaccination for both girls and boys. Recent studies suggest that spouses of people with oral cancer are not themselves at higher risk, 2 vaccine doses may work as well as 1, and vaccination has already reduced genital warts in Australia.
U.S. Cancer Rates Fall Overall, but Some HPV-associated Cancers Rise
- Details
- Category: Human Papillomavirus (HPV)
- Published on Tuesday, 15 January 2013 00:00
- Written by Liz Highleyman
Deaths due to all types of cancer combined decreased for men and women of all racial/ethnic groups in the U.S., according to a joint "Annual Report to the Nation," published in the January 7, 2013, advance edition of the Journal of the National Cancer Institute. Incidence of oral and anal cancer increased, however, leading the report authors to call for wider use of human papillomavirus (HPV) vaccines.
Gardasil HPV Vaccine Approved for Anal Cancer
- Details
- Category: Human Papillomavirus (HPV)
- Published on Friday, 07 January 2011 12:55
- Written by FDA
On December 22, 2010, the U.S. Food and Drug Administration (FDA) approved the use of Merck's quadrivalent human papillomavirus (HPV) vaccine, Gardasil, for prevention of anal cancer in men and women age 9-26 years. The vaccine -- which targets high-risk HPV types 6, 11, 16, and 18 -- was previously approved for prevention of cervical cancer in young women.
HPV Vaccine Reduces Cervical Abnormalities
- Details
- Category: Anal & Cervical Cancer
- Published on Tuesday, 05 July 2011 12:32
- Written by Liz Highleyman
Vaccination of young women in Australia against human papillomavirus (HPV) lowered incidence of serious cervical cell abnormalities and early cervical cancer by nearly 40%.